Message #42 From:
allagher Date: August 5, 2009 02:30:09 AM
Denderon (DNDN) and Quantum Immunologics
Denderon has technology that will make current prostate cancer therapies a horror of the past. However, there is another company Quantum Immunologics, that has the same immunotherapy technology as Denderon, but it is applicable to 500 cancers instead of just one. Quantum is not a public company but 20% of it is owned by MNTR Mentor Capital. MNTR is underpriced at only 1.05 while Denderon closed at 24.51. I dont understand why anyone didnt catch on to Mentor like they did Denderon.
